Metabolomic profiling of uremic solutes in CKD patients

Takafumi Toyohara, Yasutoshi Akiyama, Takehiro Suzuki, Yoichi Takeuchi, Eikan Mishima, Masayuki Tanemoto, Ayako Momose, Naoko Toki, Hiroshi Sato, Masaaki Nakayama, Atsushi Hozawa, Ichiro Tsuji, Sadayoshi Ito, Tomoyoshi Soga, Takaaki Abe

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Early detection and accurate monitoring of patients with chronic kidney disease (CKD) is likely to improve care and decrease the risk of cardiovascular and cerebrovascular diseases. As a new diagnostic tool, we examined the retention of uremic solutes as a simpler, more accurate method to assess renal function. To achieve this, we comprehensively evaluated these solutes in CKD patients. By capillary electrophoresis with mass spectrometry, we found 22 cations and 30 anions that accumulated significantly as the estimated glomerular filtration rate (eGFR) decreased. These compounds included 9 cations and 27 anions that were newly identified in this study. In contrast, we also found 7 cations (2 new) and 5 anions (all new) that decrease significantly as eGFR declines. We evaluated each substance for its suitability to detect early CKD stage. Compounds that are highly correlated with eGFR and whose plasma concentration changed in a manner approximated by the first-degree equation are excellent candidates for detecting CKD and identifying uremic toxins that might aggravate kidney function in the early stage of CKD. These results identify a number of uremic compounds, many of which are novel and which predict worsening renal function. These compounds provide diagnostic information and may be targets for therapies designed to treat the complications of CKD patients.

Original languageEnglish
Pages (from-to)944-952
Number of pages9
JournalHypertension Research
Volume33
Issue number9
DOIs
Publication statusPublished - 2010 Sep

Fingerprint

Metabolomics
Chronic Renal Insufficiency
Glomerular Filtration Rate
Anions
Cations
Kidney
Cerebrovascular Disorders
Capillary Electrophoresis
Physiologic Monitoring
Mass Spectrometry
Cardiovascular Diseases

Keywords

  • biomarker
  • CE-MS
  • CKD
  • uremic toxin

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Toyohara, T., Akiyama, Y., Suzuki, T., Takeuchi, Y., Mishima, E., Tanemoto, M., ... Abe, T. (2010). Metabolomic profiling of uremic solutes in CKD patients. Hypertension Research, 33(9), 944-952. https://doi.org/10.1038/hr.2010.113

Metabolomic profiling of uremic solutes in CKD patients. / Toyohara, Takafumi; Akiyama, Yasutoshi; Suzuki, Takehiro; Takeuchi, Yoichi; Mishima, Eikan; Tanemoto, Masayuki; Momose, Ayako; Toki, Naoko; Sato, Hiroshi; Nakayama, Masaaki; Hozawa, Atsushi; Tsuji, Ichiro; Ito, Sadayoshi; Soga, Tomoyoshi; Abe, Takaaki.

In: Hypertension Research, Vol. 33, No. 9, 09.2010, p. 944-952.

Research output: Contribution to journalArticle

Toyohara, T, Akiyama, Y, Suzuki, T, Takeuchi, Y, Mishima, E, Tanemoto, M, Momose, A, Toki, N, Sato, H, Nakayama, M, Hozawa, A, Tsuji, I, Ito, S, Soga, T & Abe, T 2010, 'Metabolomic profiling of uremic solutes in CKD patients', Hypertension Research, vol. 33, no. 9, pp. 944-952. https://doi.org/10.1038/hr.2010.113
Toyohara T, Akiyama Y, Suzuki T, Takeuchi Y, Mishima E, Tanemoto M et al. Metabolomic profiling of uremic solutes in CKD patients. Hypertension Research. 2010 Sep;33(9):944-952. https://doi.org/10.1038/hr.2010.113
Toyohara, Takafumi ; Akiyama, Yasutoshi ; Suzuki, Takehiro ; Takeuchi, Yoichi ; Mishima, Eikan ; Tanemoto, Masayuki ; Momose, Ayako ; Toki, Naoko ; Sato, Hiroshi ; Nakayama, Masaaki ; Hozawa, Atsushi ; Tsuji, Ichiro ; Ito, Sadayoshi ; Soga, Tomoyoshi ; Abe, Takaaki. / Metabolomic profiling of uremic solutes in CKD patients. In: Hypertension Research. 2010 ; Vol. 33, No. 9. pp. 944-952.
@article{1d53dcb7a9f240a3abacf4cce7f6d9fa,
title = "Metabolomic profiling of uremic solutes in CKD patients",
abstract = "Early detection and accurate monitoring of patients with chronic kidney disease (CKD) is likely to improve care and decrease the risk of cardiovascular and cerebrovascular diseases. As a new diagnostic tool, we examined the retention of uremic solutes as a simpler, more accurate method to assess renal function. To achieve this, we comprehensively evaluated these solutes in CKD patients. By capillary electrophoresis with mass spectrometry, we found 22 cations and 30 anions that accumulated significantly as the estimated glomerular filtration rate (eGFR) decreased. These compounds included 9 cations and 27 anions that were newly identified in this study. In contrast, we also found 7 cations (2 new) and 5 anions (all new) that decrease significantly as eGFR declines. We evaluated each substance for its suitability to detect early CKD stage. Compounds that are highly correlated with eGFR and whose plasma concentration changed in a manner approximated by the first-degree equation are excellent candidates for detecting CKD and identifying uremic toxins that might aggravate kidney function in the early stage of CKD. These results identify a number of uremic compounds, many of which are novel and which predict worsening renal function. These compounds provide diagnostic information and may be targets for therapies designed to treat the complications of CKD patients.",
keywords = "biomarker, CE-MS, CKD, uremic toxin",
author = "Takafumi Toyohara and Yasutoshi Akiyama and Takehiro Suzuki and Yoichi Takeuchi and Eikan Mishima and Masayuki Tanemoto and Ayako Momose and Naoko Toki and Hiroshi Sato and Masaaki Nakayama and Atsushi Hozawa and Ichiro Tsuji and Sadayoshi Ito and Tomoyoshi Soga and Takaaki Abe",
year = "2010",
month = "9",
doi = "10.1038/hr.2010.113",
language = "English",
volume = "33",
pages = "944--952",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Metabolomic profiling of uremic solutes in CKD patients

AU - Toyohara, Takafumi

AU - Akiyama, Yasutoshi

AU - Suzuki, Takehiro

AU - Takeuchi, Yoichi

AU - Mishima, Eikan

AU - Tanemoto, Masayuki

AU - Momose, Ayako

AU - Toki, Naoko

AU - Sato, Hiroshi

AU - Nakayama, Masaaki

AU - Hozawa, Atsushi

AU - Tsuji, Ichiro

AU - Ito, Sadayoshi

AU - Soga, Tomoyoshi

AU - Abe, Takaaki

PY - 2010/9

Y1 - 2010/9

N2 - Early detection and accurate monitoring of patients with chronic kidney disease (CKD) is likely to improve care and decrease the risk of cardiovascular and cerebrovascular diseases. As a new diagnostic tool, we examined the retention of uremic solutes as a simpler, more accurate method to assess renal function. To achieve this, we comprehensively evaluated these solutes in CKD patients. By capillary electrophoresis with mass spectrometry, we found 22 cations and 30 anions that accumulated significantly as the estimated glomerular filtration rate (eGFR) decreased. These compounds included 9 cations and 27 anions that were newly identified in this study. In contrast, we also found 7 cations (2 new) and 5 anions (all new) that decrease significantly as eGFR declines. We evaluated each substance for its suitability to detect early CKD stage. Compounds that are highly correlated with eGFR and whose plasma concentration changed in a manner approximated by the first-degree equation are excellent candidates for detecting CKD and identifying uremic toxins that might aggravate kidney function in the early stage of CKD. These results identify a number of uremic compounds, many of which are novel and which predict worsening renal function. These compounds provide diagnostic information and may be targets for therapies designed to treat the complications of CKD patients.

AB - Early detection and accurate monitoring of patients with chronic kidney disease (CKD) is likely to improve care and decrease the risk of cardiovascular and cerebrovascular diseases. As a new diagnostic tool, we examined the retention of uremic solutes as a simpler, more accurate method to assess renal function. To achieve this, we comprehensively evaluated these solutes in CKD patients. By capillary electrophoresis with mass spectrometry, we found 22 cations and 30 anions that accumulated significantly as the estimated glomerular filtration rate (eGFR) decreased. These compounds included 9 cations and 27 anions that were newly identified in this study. In contrast, we also found 7 cations (2 new) and 5 anions (all new) that decrease significantly as eGFR declines. We evaluated each substance for its suitability to detect early CKD stage. Compounds that are highly correlated with eGFR and whose plasma concentration changed in a manner approximated by the first-degree equation are excellent candidates for detecting CKD and identifying uremic toxins that might aggravate kidney function in the early stage of CKD. These results identify a number of uremic compounds, many of which are novel and which predict worsening renal function. These compounds provide diagnostic information and may be targets for therapies designed to treat the complications of CKD patients.

KW - biomarker

KW - CE-MS

KW - CKD

KW - uremic toxin

UR - http://www.scopus.com/inward/record.url?scp=77956402544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956402544&partnerID=8YFLogxK

U2 - 10.1038/hr.2010.113

DO - 10.1038/hr.2010.113

M3 - Article

VL - 33

SP - 944

EP - 952

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 9

ER -